National Medical Care Company (TADAWUL:4005)
Saudi Arabia · Delayed Price · Currency is SAR 104.70
-1.90 (-1.78%)
Nov 5, 2026, 3:18 PM AST
TADAWUL:4005 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,721 | 1,600 | 1,294 | 1,082 | 917.93 | 845.38 | |
Revenue Growth | 9.73% | 23.71% | 19.59% | 17.85% | 8.58% | 4.50% |
Cost of Revenue | 1,192 | 1,017 | 847.98 | 714.93 | 630.99 | 601.08 |
Gross Profit | 528.9 | 582.88 | 445.7 | 366.85 | 286.95 | 244.3 |
Selling, General & Admin | 175.16 | 211.97 | 168.23 | 124.53 | 93.08 | 79.09 |
Other Operating Expenses | -1.49 | -1.4 | -6.33 | -4.03 | -8.35 | -8.19 |
Operating Expenses | 180.99 | 228.34 | 194.62 | 120.13 | 89.68 | 79.9 |
Operating Income | 347.91 | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 |
Interest Expense | -21.58 | -26.97 | -22.74 | -3.5 | - | - |
Interest & Investment Income | 10.09 | 18.8 | 19.48 | 21.37 | 1.24 | - |
EBT Excluding Unusual Items | 336.43 | 346.36 | 247.83 | 264.59 | 198.5 | 164.4 |
Legal Settlements | - | - | 42.34 | - | - | - |
Pretax Income | 336.43 | 346.36 | 290.16 | 264.59 | 198.5 | 164.4 |
Income Tax Expense | 32.01 | 27.89 | -4.54 | 23.67 | 28.43 | 28.04 |
Net Income | 304.42 | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 |
Net Income to Common | 304.42 | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 |
Net Income Growth | -9.05% | 8.07% | 22.32% | 41.66% | 24.73% | 40.18% |
Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | 45 |
Shares Change | -0.03% | -0.17% | -0.18% | - | - | - |
EPS (Basic) | 6.81 | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 |
EPS (Diluted) | 6.81 | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 |
EPS Growth | -9.01% | 8.25% | 22.54% | 41.66% | 24.73% | 40.18% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 80.43 | 26.8 | 136.63 | 412.73 | 185.83 | 61.61 |
Free Cash Flow Per Share | 1.80 | 0.60 | 3.05 | 9.20 | 4.14 | 1.37 |
Dividend Per Share | - | 3.000 | 2.000 | 2.000 | 1.000 | 1.000 |
Dividend Growth | - | 50.00% | 0% | 100.00% | 0% | 0% |
Gross Margin | 30.74% | 36.42% | 34.45% | 33.91% | 31.26% | 28.90% |
Operating Margin | 20.22% | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% |
Profit Margin | 17.69% | 19.90% | 22.78% | 22.27% | 18.53% | 16.13% |
Free Cash Flow Margin | 4.67% | 1.68% | 10.56% | 38.15% | 20.24% | 7.29% |
EBITDA | 426.69 | 437.75 | 315.14 | 290.94 | 239.17 | 214.56 |
EBITDA Margin | 24.80% | 27.35% | 24.36% | 26.90% | 26.05% | 25.38% |
D&A For EBITDA | 78.78 | 83.21 | 64.06 | 44.22 | 41.9 | 50.16 |
EBIT | 347.91 | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 |
EBIT Margin | 20.22% | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% |
Effective Tax Rate | 9.52% | 8.05% | - | 8.95% | 14.32% | 17.06% |